Press releases
- QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
- QuidelOrtho To Report First Quarter 2024 Financial Results
- Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives
- Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Company and Certain Executives
- QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
- QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
- QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
- QuidelOrtho Announces Changes in Executive Leadership
- QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 66.88m |
Free float | 53.48m |
P/E (TTM) | -- |
Market cap | 2.65bn USD |
EPS (TTM) | -0.1542 USD |
--
More ▼